Q: UEX is moving. It was 50 cents not too long ago and in about a month it dropped to 38 cents today. Can you please provide me with the most accurate website depicting the live price for uranium?What do you think about the future of this company and the supply and demand of uranium. You think UEX and uranium spot price will move alot over the summer? Or will it drop quickly over the summer?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: what are your thoughts on POET tech today
Thank You
Peter
Thank You
Peter
Q: What exactly is holding Surge back from participating in rising oil prices? You would think their debt load and hedges and perhaps just the entire oil industry being out of favour are so yesterdays news. Looking forward for Surge, do you still see a viable company?
Q: July 2nd I asked if NEXE was a buy sell or hold . your reply ,was that you do not give that type advice. you did not give that same answer today about a similar question regarding STOR why??????? I will ask in a different way ___ my break even price on NEXE is 1.37 other sites have said this will go to .92 cents is this 5i opinion; is this worth keeping in hope that their wrong
Q: Hello. I started a new position in BRAG in Jan, 2021 and I am down 47% to date. Is this a good time to add or should I wait a little longer?
Q: Gritstone Bio (GRTS) is a small, early-stage biotech company to which Gilead Sciences has provided some funding under an agreement announced on Feb 1, 2021:
"Under the terms of the agreement, Gilead will make a $60 million payment at closing, consisting of a $30 million upfront cash payment and a $30 million equity investment at a premium. Gilead will be responsible for conducting a Phase 1 study for the HIV-specific therapeutic vaccine and holds an exclusive option under the collaboration to obtain an exclusive license to develop and commercialize the HIV-specific therapeutic vaccine beyond Phase 1. Gritstone is also eligible to receive up to an additional $725 million if the option is exercised and if certain clinical, regulatory and commercial milestones are achieved, as well as mid single-digit to low double-digit tiered royalties on net sales upon commercialization."
GRTS share price has established a baseline after falling steadily since the funding announcement. Presumably Gilead did some due diligence before investing its own money, but the stock price could go to zero if Gilead walks away. However, it could also soar if the trials are successful. Would you consider GRTS to be a worthwhile speculative buy? What has been your experience of investing in early-stage biotech companies that have drawn the attention of Big Pharma?
"Under the terms of the agreement, Gilead will make a $60 million payment at closing, consisting of a $30 million upfront cash payment and a $30 million equity investment at a premium. Gilead will be responsible for conducting a Phase 1 study for the HIV-specific therapeutic vaccine and holds an exclusive option under the collaboration to obtain an exclusive license to develop and commercialize the HIV-specific therapeutic vaccine beyond Phase 1. Gritstone is also eligible to receive up to an additional $725 million if the option is exercised and if certain clinical, regulatory and commercial milestones are achieved, as well as mid single-digit to low double-digit tiered royalties on net sales upon commercialization."
GRTS share price has established a baseline after falling steadily since the funding announcement. Presumably Gilead did some due diligence before investing its own money, but the stock price could go to zero if Gilead walks away. However, it could also soar if the trials are successful. Would you consider GRTS to be a worthwhile speculative buy? What has been your experience of investing in early-stage biotech companies that have drawn the attention of Big Pharma?
Q: What do you think of the mid to long term growth of POOL and SPWH?
Q: Ah! The widow and orphan stock.
What do you think? After all these years of never being able to gain traction, is now their time?
Just like nvdia when it did nothing for years and then became the darling of the street. Been burnt twice with Sierra but I sense a huge turnaround with 5G or a buyout!
Peter: your opinion! Thanks.
What do you think? After all these years of never being able to gain traction, is now their time?
Just like nvdia when it did nothing for years and then became the darling of the street. Been burnt twice with Sierra but I sense a huge turnaround with 5G or a buyout!
Peter: your opinion! Thanks.
Q: What are your thoughts on Atomera? Would you consider them a buy at current prices?
Q: Hello,
Any change in your view of this Company, since dropping like a lead balloon?
Any change in your view of this Company, since dropping like a lead balloon?
Q: Baught NEO at $20.08 on May 3rd and has since been going down, Should I hold on or get out, the last financial report was very good.
Thanks for the insight.
Thanks for the insight.
Q: What is your opinion of this stock given latest news
Thanks Mike B
Thanks Mike B
Q: AVP, although apparently profitable, seems in very dire straits with their high (though improving) debt levels, etc. Can they survive and what is your estimation of its potential value?
Q: Hi 5i
Vtnr -vertex energy, is not currently in your data base.
It recently joined russell microcap index is an environmental services company and recycles motor oil...
I would like your opinion on this company and if it is something that would interest you as an investment. It has recently had several upgrades as far as i can tell...
Do you think share price has gone too far too fast?
Thx
Jim
Vtnr -vertex energy, is not currently in your data base.
It recently joined russell microcap index is an environmental services company and recycles motor oil...
I would like your opinion on this company and if it is something that would interest you as an investment. It has recently had several upgrades as far as i can tell...
Do you think share price has gone too far too fast?
Thx
Jim
Q: With PHO going private which technology stock would be best to replace it with? I currently own OTEX and LSPD
Thanks
Thanks
Q: could you help me understand xebecs income stream is it basicaly in constructing and maintaining ... can or do they have a chance to get a piece of the fill up station thanks for your effort in this....
Q: I'm looking for small caps to replace the nice win with PHO and want to increase my exposure to Healthcare. Do you have any thoughts on these names for exposure in this space? Thank you.
Q: I am now break even on kwe after recently being down 35 percent. Should I cut and run, trim, or hold. What is your outlook. Thanks
Q: Hello,
Do you have any info on this company? It is involved in supplying lithium ion batteries to the EV market. Jeff Dahn is the principal architect from Dalhousie University. He also has a renewable contract with Tesla. It trades on the Aussie market along OTC in the USA.
Thanks
Rick
Do you have any info on this company? It is involved in supplying lithium ion batteries to the EV market. Jeff Dahn is the principal architect from Dalhousie University. He also has a renewable contract with Tesla. It trades on the Aussie market along OTC in the USA.
Thanks
Rick
Q: Now that the deal is done. If one were to hold their shares and wait for the transaction to close when would shares be paid out approximately? Thx